Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk

S L Kopecky1, B J Gersh, M D McGoon

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.

Insights

Lone atrial fibrillation after age 60 significantly increases cardiovascular event risk compared to the general population. This finding suggests antithrombotic therapy may be warranted for older individuals with LAF.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Epidemiology

Background:

  • Lone atrial fibrillation (LAF) in individuals under 60 does not elevate stroke risk above general population levels.
  • The cardiovascular risk associated with LAF in individuals over 60 remains less understood.

Purpose of the Study:

  • To investigate the risk of stroke and other cardiovascular events in older adults (aged 60+) diagnosed with lone atrial fibrillation.
  • To compare cardiovascular event rates in older LAF patients with an age- and sex-matched control group.

Main Methods:

  • A population-based study was conducted at a single institution.
  • 55 patients with LAF (mean age 74) and without significant comorbidities were compared to age- and sex-matched controls.
  • Follow-up averaged 9.6 years, monitoring for cardiovascular events including stroke, transient ischemic attacks, and myocardial infarction.

Main Results:

  • Patients with LAF experienced significantly higher rates of total cardiovascular events (5.0% per person-year) compared to controls (1.3% per person-year).
  • Specific event rates for LAF patients included 0.9% for stroke, 1.1% for transient cerebral ischemia, and 2.6% for myocardial infarction.
  • While cardiovascular event incidence was higher, survival rates did not differ between the LAF and control groups.

Conclusions:

  • Lone atrial fibrillation diagnosed after age 60 serves as a significant risk marker for increased cardiovascular events.
  • These findings support the consideration of antithrombotic therapy for older individuals diagnosed with LAF to mitigate cardiovascular risk.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...